KB

Kush Bhatia

Active Director Director DIN 07891229
DIN 07891229 First appointment May 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Kush Bhatia

Data last updated:

Kush Bhatia is a Director at Panacea Medicorp Private Limited (since 2025). The company operates in Healthcare.

DIN 07891229
Primary Designation Director
Industry Healthcare
First Appointment 04 May 2025
Oldest Company Age 9 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Panacea Medicorp Private Limited U74999DL2017PTC322299
Director04 May 20252017Active

Directorship timeline

Open interactive timeline →
Panacea Medicorp Private Limited
Premium access

Shareholding and investment profile for Kush Bhatia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kush Bhatia

Kush Bhatia currently holds 1 directorship: Panacea Medicorp Private Limited (Director, since 04 May 2025).

Kush Bhatia was first appointed on 04 May 2025 as Director at Panacea Medicorp Private Limited.

The current boards of Kush Bhatia's companies include Damanbir Singh (Panacea Medicorp Private Limited), Deepanshi Garg (Panacea Medicorp Private Limited), Kapil Sangwan (Panacea Medicorp Private Limited), Manoop Mittal (Panacea Medicorp Private Limited), Monika Malik (Panacea Medicorp Private Limited), Vinod Malik (Panacea Medicorp Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available